Bioavailability (BA) and bioequivalence (BE) studies ensure that generic drugs provide the same therapeutic effect as their branded equivalents. Regulatory authorities worldwide validate the safety and efficacy of generic medicines through these studies before allowing them into their markets. However, the acceptance of BA/BE studies varies from country to country, with different criteria for approving […]

Read More →

Bioavailability (BA) and bioequivalence (BE) studies in India are crucial in drug development and regulatory approval processes. These studies ensure that generic drugs are therapeutically equivalent to their branded counterparts and that new formulations perform adequately. The importance of BA/BE studies has grown significantly in India, driven by the burgeoning pharmaceutical industry and stringent regulatory […]

Read More →